Your browser doesn't support javascript.
loading
Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.
Gayden, Tenzin; Sepulveda, Fernando E; Khuong-Quang, Dong-Anh; Pratt, Jonathan; Valera, Elvis T; Garrigue, Alexandrine; Kelso, Susan; Sicheri, Frank; Mikael, Leonie G; Hamel, Nancy; Bajic, Andrea; Dali, Rola; Deshmukh, Shriya; Dervovic, Dzana; Schramek, Daniel; Guerin, Frédéric; Taipale, Mikko; Nikbakht, Hamid; Majewski, Jacek; Moshous, Despina; Charlebois, Janie; Abish, Sharon; Bole-Feysot, Christine; Nitschke, Patrick; Bader-Meunier, Brigitte; Mitchell, David; Thieblemont, Catherine; Battistella, Maxime; Gravel, Simon; Nguyen, Van-Hung; Conyers, Rachel; Diana, Jean-Sebastien; McCormack, Chris; Prince, H Miles; Besnard, Marianne; Blanche, Stephane; Ekert, Paul G; Fraitag, Sylvie; Foulkes, William D; Fischer, Alain; Neven, Bénédicte; Michonneau, David; de Saint Basile, Geneviève; Jabado, Nada.
Afiliación
  • Gayden T; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Sepulveda FE; Laboratory of Normal and Pathological Homeostasis of the Immune System, INSERM U1163, Institut Imagine, and Université Paris Descartes-Sorbonne Paris Cité, Paris, France.
  • Khuong-Quang DA; Children's Cancer Center, The Royal Children's Hospital and Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Pratt J; Department of Pediatrics, University of Melbourne, Parkville, Victoria, Australia.
  • Valera ET; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Garrigue A; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Kelso S; Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Sicheri F; Laboratory of Normal and Pathological Homeostasis of the Immune System, INSERM U1163, Institut Imagine, and Université Paris Descartes-Sorbonne Paris Cité, Paris, France.
  • Mikael LG; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Hamel N; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Bajic A; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Dali R; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Deshmukh S; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Dervovic D; Cancer Research Program, Research Institute of the McGill University Health Center, Montreal, Quebec, Canada.
  • Schramek D; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Guerin F; Canadian Centre for Computational Genomics, Montreal, Quebec, Canada.
  • Taipale M; Department of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
  • Nikbakht H; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Majewski J; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Moshous D; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Charlebois J; Laboratory of Normal and Pathological Homeostasis of the Immune System, INSERM U1163, Institut Imagine, and Université Paris Descartes-Sorbonne Paris Cité, Paris, France.
  • Abish S; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Bole-Feysot C; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Nitschke P; Canadian Centre for Computational Genomics, Montreal, Quebec, Canada.
  • Bader-Meunier B; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
  • Mitchell D; McGill University and Genome Quebec Innovation Center, Montreal, Quebec, Canada.
  • Thieblemont C; Department of Pediatric Immunology and Hematology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Battistella M; Division of Hematology and Oncology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
  • Gravel S; Division of Hematology and Oncology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
  • Nguyen VH; Plateforme de Génomique, Institut Imagine, Paris, France.
  • Conyers R; Plateforme de Bioinformatique, Université Paris Descartes, Université Sorbonne Paris Cité, Paris, France.
  • Diana JS; Department of Pediatric Immunology and Hematology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • McCormack C; Division of Hematology and Oncology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
  • Prince HM; Hematology and Oncology Unit, Saint Louis Hospital, Paris, France.
  • Besnard M; Paris Diderot University, Université Sorbonne Paris Cité, Paris, France.
  • Blanche S; Paris Diderot University, Université Sorbonne Paris Cité, Paris, France.
  • Ekert PG; Cytology and Pathology Laboratory, Saint Louis Hospital, Paris, France.
  • Fraitag S; McGill University and Genome Quebec Innovation Center, Montreal, Quebec, Canada.
  • Foulkes WD; Department of Pathology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
  • Fischer A; Children's Cancer Center, The Royal Children's Hospital and Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Neven B; Department of Pediatrics, University of Melbourne, Parkville, Victoria, Australia.
  • Michonneau D; Department of Pediatric Immunology and Hematology, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • de Saint Basile G; Department of Surgical Oncology, Peter MacCallum Cancer Institute, University of Melbourne, Melbourne, Victoria, Australia.
  • Jabado N; Department of Dermatology, St. Vincent's Hospital, Fitzroy, Victoria, Australia.
Nat Genet ; 51(1): 196, 2019 01.
Article en En | MEDLINE | ID: mdl-30429576
In the version of this article originally published, the main-text sentence "In three patients of European ancestry, we identified the germline variant encoding p.Ile97Met in TIM-3, which was homozygous in two (P12 and P13) and heterozygous in one (P15) in the germline but with no TIM-3 plasma membrane expression in the tumor" misstated the identifiers of the two homozygous individuals, which should have been P13 and P14. The error has been corrected in the HTML, PDF and print versions of the paper.
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Nat Genet Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article País de afiliación: Canadá